Role of 5-HT2A Receptor Gene T102C Polymorphism in Coronary Artery Disease and Serum Lipid Level.
10.4070/kcj.2003.33.4.269
- Author:
Jin Ho CHOI
1
;
Shu Ying ZHANG
;
Young Seok CHO
;
Kyoung Kook WHANG
;
Jun Hee LEE
;
Seil OH
;
In Ho CHAE
;
Joo Hee ZO
;
Hyo Soo KIM
;
Byung Hee OH
;
Myoung Mook LEE
;
Yun Shik CHOI
;
Young Bae PARK
Author Information
1. Cardiovascular Center, Seoul National University Hospital, Seoul, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Cholesterol;
Serotonin;
Polymorphism
- MeSH:
Angiography;
Cholesterol;
Coronary Artery Disease*;
Coronary Vessels*;
DNA;
Genotype;
Humans;
Hypertension;
Mental Disorders;
Multivariate Analysis;
Muscle Spasticity;
Myocardial Infarction;
Polymorphism, Genetic;
Receptor, Serotonin, 5-HT2A*;
RNA, Messenger;
Serotonin;
Serotonin 5-HT2 Receptor Antagonists;
Vasoconstriction
- From:Korean Circulation Journal
2003;33(4):269-276
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND AND OBJECTIVES: The 5-HT2A receptor is one of the main mediators of a serotonin-evoked coronary artery contraction. This is because vasoconstriction is selectively blocked by the 5-HT2 receptor antagonist, with the 5-HT2A receptor gene mRNA being detected in spastic coronary arteries. The relationship between the T102C polymorphism of the 5-HT2A receptor gene and the response to the 5-HT2A antagonist (clozapine) has recently been established, suggestive of a functional implication. Previous studies have observed an association between low cholesterol levels and mental disorders, but the underlying cause has not been determined. It has been established that the T102C polymorphism of the 5-HT2A serotonin receptor gene and a variety of psychological problems are related, but the relationship between the serum lipid level and this genetic polymorphism has not been reported. We investigated the influence of this polymorphism on coronary artery disease, including vasospastic angina and the clinical parameters, such as the lipid profile. SUBJECTS AND METHODS: After a diagnostic angiography was performed, the genotype was identified from the genomic DNA extracted from the peripheral blood of 646 patients without specific psychiatric diseases. RESULTS: There were no differences in the genotype frequencies between coronary artery disease, coronary artery disease with vasospasm, and the normal control groups, even from a subgroup analysis of the clinical parameters. Contrary to previous reports, the genotype distribution was not related to a myocardial infarction or hypertension. The lipid profile analysis showed significantly lower total cholesterol (193.5 vs. 202.1mg/dL, p=0.016) and HDL-cholesterol (42.7 vs. 46.2mg/dL, p=0.003) levels in the CC genotype than the other genotypes, and the frequencies of CC genotype showed a significantly decreasing trend between the HDL-cholesterol (p=0.003) and total cholesterol (p=0.003) quartiles. From a multivariate analysis, only the HDL-cholesterol level was significantly associated with a lower frequency of the CC genotype (p=0.006). CONCLUSION: The T102C polymorphism is not related to coronary artery disease, including vasospasm of the coronary artery, but the CC genotype of this polymorphism is related to low HDL-cholesterol. We identified a novel genetic polymorphism of the serotonin receptor, which affects the HDL-cholesterol level. Because previous observational studies have shown an association between low cholesterol levels and mental disorders, our data should be considered when analyzing the serum lipid levels and serotonin receptor function in humans.
